Daniela E. Matei

Hematology | Oncology

250 E Superior St Ste 4-420
Prentice Women's Hospital
Chicago, IL 60611

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 143 publications

Blood Based Biomarkers of DNA Methylation Associated with Platinum Resistance in High Grade Serous Ovarian Cancer.

Blood Based Biomarkers of DNA Methylation Associated with Platinum Resistance in High Grade Serous Ovarian Cancer.

Journal: bioRxiv : the preprint server for biology

Published: May 04, 2026

Surgical window of opportunity clinical trial of abemaciclib and letrozole for endometrioid adenocarcinoma of the endometrium.

Surgical window of opportunity clinical trial of abemaciclib and letrozole for endometrioid adenocarcinoma of the endometrium.

Journal: Gynecologic oncology

Published: April 19, 2026

Effects of the Hypomethylating Agent Guadecitabine on Peripheral Blood Mononuclear Cell Methylomes and Immune Cell Populations in Small-Cell Lung Cancer Patients.

Effects of the Hypomethylating Agent Guadecitabine on Peripheral Blood Mononuclear Cell Methylomes and Immune Cell Populations in Small-Cell Lung Cancer Patients.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: March 05, 2026

Effects of the Hypomethylating Agent Guadecitabine on Peripheral Blood Mononuclear Cell Methylomes and Immune Cell Populations in Small-Cell Lung Cancer Patients.

Effects of the Hypomethylating Agent Guadecitabine on Peripheral Blood Mononuclear Cell Methylomes and Immune Cell Populations in Small-Cell Lung Cancer Patients.

Journal: bioRxiv : the preprint server for biology

Published: February 27, 2026

Epitranscriptomic Regulation of Platinum Resistance via the METTL3-ADAM23 Axis in Ovarian Cancer.

Epitranscriptomic Regulation of Platinum Resistance via the METTL3-ADAM23 Axis in Ovarian Cancer.

Journal: Cells

Published: December 16, 2025

Oleic acid fuels cisplatin-resistant ovarian cancer through FABP4-driven lipid uptake.

Oleic acid fuels cisplatin-resistant ovarian cancer through FABP4-driven lipid uptake.

Journal: Molecular metabolism

Published: December 16, 2025

Phase Ib trial of SL-172154, a bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, in combination with mirvetuximab soravtansine or pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer.

Phase Ib trial of SL-172154, a bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, in combination with mirvetuximab soravtansine or pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer.

Journal: British journal of cancer

Published: September 20, 2025

Novel PROTACs targeting tissue transglutaminase (TG2) suppress tumorigenicity of ovarian cancer cells.

Novel PROTACs targeting tissue transglutaminase (TG2) suppress tumorigenicity of ovarian cancer cells.

Journal: European journal of medicinal chemistry

Published: August 15, 2025

Mid-Infrared Photothermal Imaging of Fatty Acid Desaturation Reaction in Cancer Cells.

Mid-Infrared Photothermal Imaging of Fatty Acid Desaturation Reaction in Cancer Cells.

Journal: bioRxiv : the preprint server for biology

Published: July 09, 2025

CRISPR screen reveals a simultaneous targeted mechanism to reduce cancer cell selenium and increase lipid oxidation to induce ferroptosis.

CRISPR screen reveals a simultaneous targeted mechanism to reduce cancer cell selenium and increase lipid oxidation to induce ferroptosis.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: May 30, 2025

Fit4Surgery: A pilot randomized controlled trial to assess the feasibility of prehabilitation prior to debulking surgery for ovarian cancer.

Fit4Surgery: A pilot randomized controlled trial to assess the feasibility of prehabilitation prior to debulking surgery for ovarian cancer.

Journal: Gynecologic oncology

Published: May 12, 2025

Reply to: Comment on The Study of NRG258: Limitations and Future Directions.

Reply to: Comment on The Study of NRG258: Limitations and Future Directions.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: April 10, 2025

Showing 1-12 of 143

Last Updated: 09/26/2026